Zions Bancorporation, National Association’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
MGP
Zions Bancorporation, National Association's BMY Position: Q2 2026 in Review
Zions Bancorporation, National Association increased its Bristol-Myers Squibb (BMY) stake by 5.1% in Q2 2026, buying an estimated $27.5K and bringing the position to 9,829 shares worth $566K. The position accounts for 0.03% of the portfolio, ranked #239.
Zions Bancorporation, National Association first reported a position in BMY in Q1 2025 and has held it in 6 quarters since. The position peaked at $10.4M in Q1 2025. 1,509 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Zions Bancorporation, National Association held 9,829 shares of Bristol-Myers Squibb worth $566K as of Q2 2026.
- Zions Bancorporation, National Association bought 479 Bristol-Myers Squibb shares in Q2 2026, an estimated $27.5K.
- Bristol-Myers Squibb made up 0.03% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #239 holding.
- Zions Bancorporation, National Association first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 6 quarters since.
- Zions Bancorporation, National Association's Bristol-Myers Squibb position peaked at $10.4M in Q1 2025.
- 1,509 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.